The single nucleotide polymorphism rs4986790 (c.896A>G) in the gene

COVID-19 IL-6 SARS-CoV-2 TLR4 disease severity polymorphism prognostic marker rs4986790

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2024
Historique:
received: 13 12 2023
accepted: 29 01 2024
medline: 4 3 2024
pubmed: 4 3 2024
entrez: 4 3 2024
Statut: epublish

Résumé

Several factors, such as hypertension and diabetes mellitus, are known to influence the course of coronavirus disease 2019 (COVID-19). However, there is currently little information on genetic markers that influence the severity of COVID-19. In this study, we specifically investigated the single nucleotide polymorphism (SNP) rs4986790 in the We analyzed the influence of demographics, pre-existing conditions, inflammatory parameters at the time of hospitalization, and We confirmed that younger patient age and absence of pre-existing conditions were protective factors against disease progression. Furthermore, when comparing patients with mild SARS-CoV-2 infection with patients who required hospitalization or intensive care or even died due to COVID-19, the AG/GG genotype of In this study, we identified an additional genetic factor that may serve as an invariant predictor of COVID-19 outcome. The

Sections du résumé

Background and aims UNASSIGNED
Several factors, such as hypertension and diabetes mellitus, are known to influence the course of coronavirus disease 2019 (COVID-19). However, there is currently little information on genetic markers that influence the severity of COVID-19. In this study, we specifically investigated the single nucleotide polymorphism (SNP) rs4986790 in the
Methods UNASSIGNED
We analyzed the influence of demographics, pre-existing conditions, inflammatory parameters at the time of hospitalization, and
Results UNASSIGNED
We confirmed that younger patient age and absence of pre-existing conditions were protective factors against disease progression. Furthermore, when comparing patients with mild SARS-CoV-2 infection with patients who required hospitalization or intensive care or even died due to COVID-19, the AG/GG genotype of
Conclusion UNASSIGNED
In this study, we identified an additional genetic factor that may serve as an invariant predictor of COVID-19 outcome. The

Identifiants

pubmed: 38433829
doi: 10.3389/fimmu.2024.1355193
pmc: PMC10904585
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1355193

Informations de copyright

Copyright © 2024 Zacher, Schönfelder, Rohn, Siffert and Möhlendick.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Christoph Zacher (C)

Institute of Pharmacogenetics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Kristina Schönfelder (K)

Department of Nephrology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Hana Rohn (H)

Department of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Winfried Siffert (W)

Institute of Pharmacogenetics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Birte Möhlendick (B)

Institute of Pharmacogenetics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Classifications MeSH